Masthead

Submit

Issues

Current Issue

February 2023

Unified Airway Disease
Devyani Lal, Angela M. Donaldson and David W. Jang, Editors

Nearly fifteen years later, advances in our understanding of airway inflammation have further refined the concept of the unified airway and have led to more targeted medical therapies. With a greater understanding of type 2 inflammation, we have seen the development and widespread use of biologics for the treatment of nasal polyps and asthma. We have also seen the impact of translational medicine on cystic fibrosis patients. The advent of CFTR modulators has transformed the way we manage the unified airway and has improved the quality of life and morbidity of these patients. With these new advances, close collaboration between otolaryngologists, allergists, pulmonologists, and other specialists has become critical for patient care.

Past Issues

Articles in Press

There are no Articles in Press at this time

Most Read

About

The Clinics Journals

Loading ...

Discover everything the Clinics journals have to offer.

About the Journal



Otolaryngologic Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in otolaryngology and is presented under the direction of an experienced guest editor.

Additional Information

Testimonial

Series Editor

Sujana S. Chandrasekhar, MD, FACS, FAAO-HNS

Podcast

Biologics in Otolaryngology

Loading ...

This edition of the Otolaryngologic Clinics Podcast features discussion on the August 2021 issue of Otolaryngologic Clinics on Biologics in Otolaryngology. Guest Editors Drs. Nicole C. Schmitt, Sarah K. Wise, and Ashkan Monfared break down the article topics with Consulting Editor Sujana S. Chandrasekhar. Articles available at: https://bit.ly/3PNwYRv

Twitter: @PlasSurgENTClin

Download MP3

All Otolaryngologic Clinics Podcasts

Advertisement